13F Portfolios

Avidity Partners Management LP — ORUKA THERAPEUTICS INC ORKA: Quarterly 13F Position History

Avidity Partners Management LP has reported ORUKA THERAPEUTICS INC (ORKA) on 7 13F-HR filings in Pactolio's tracked window, first appearing in Q3 2024. As of Q1 2026, the position is sized at 760,424 shares ($52.0M market value, 11.77% of the equity book). Quarter-over-quarter share count change: + 100,000 (+15.1%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 760,424 +100,000 +15.1% $52.0M 11.77% $68.41
Q4 2025 660,424 0 $20.0M 5.77% $30.31
Q3 2025 660,424 +308,300 +87.6% $12.7M 2.89% $19.23
Q2 2025 352,124 0 $3.9M 0.79% $11.21
Q1 2025 352,124 0 $3.6M 0.75% $10.26
Q4 2024 352,124 438,802 -55.5% $6.8M 0.68% $19.39
Q3 2024 790,926 $19.4M 0.99% $24.51

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Avidity Partners Management LP first disclose a ORKA position in 13F-HR filings?

Avidity Partners Management LP first reported ORUKA THERAPEUTICS INC (ORKA) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.

What was Avidity Partners Management LP's most recent quarter-over-quarter share-count change in ORKA?

Between Q4 2025 and Q1 2026, Avidity Partners Management LP added 100,000 shares of ORKA (+15.1%), bringing the total reported position to 760,424 shares at a market value of $52.0M.

Does the implied price-per-share represent Avidity Partners Management LP's cost basis in ORKA?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.